These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 34241567)

  • 21. Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease.
    Ma HQ; Yu TT; Zhao XJ; Zhang Y; Zhang HJ
    World J Gastroenterol; 2018 Apr; 24(13):1464-1477. PubMed ID: 29632427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A microbial signature for Crohn's disease.
    Pascal V; Pozuelo M; Borruel N; Casellas F; Campos D; Santiago A; Martinez X; Varela E; Sarrabayrouse G; Machiels K; Vermeire S; Sokol H; Guarner F; Manichanh C
    Gut; 2017 May; 66(5):813-822. PubMed ID: 28179361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations in the gut mycobiome with coronary artery disease severity.
    An K; Jia Y; Xie B; Gao J; Chen Y; Yuan W; Zhong J; Su P; Liu X
    EBioMedicine; 2024 May; 103():105137. PubMed ID: 38703606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal dynamics of gut bacteriome and mycobiome interactions pre- and post-visceral surgery in Crohn's disease.
    Wetzel S; Müller A; Kohnert E; Mehrbarzin N; Huber R; Häcker G; Kreutz C; Lederer AK; Badr MT
    Front Cell Infect Microbiol; 2023; 13():1275405. PubMed ID: 38287975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge.
    Zuo T; Zhan H; Zhang F; Liu Q; Tso EYK; Lui GCY; Chen N; Li A; Lu W; Chan FKL; Chan PKS; Ng SC
    Gastroenterology; 2020 Oct; 159(4):1302-1310.e5. PubMed ID: 32598884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between fecal bile acids and microbiome community structure in pediatric Crohn's disease.
    Connors J; Dunn KA; Allott J; Bandsma R; Rashid M; Otley AR; Bielawski JP; Van Limbergen J
    ISME J; 2020 Mar; 14(3):702-713. PubMed ID: 31796936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut bacterial and fungal dysbiosis in tuberculosis patients.
    Han M; Wang X; Zhang J; Su L; Ishaq HM; Li D; Cui J; Zhao H; Yang F
    BMC Microbiol; 2024 Apr; 24(1):141. PubMed ID: 38658829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fungal Microbiota Profile in Newly Diagnosed Treatment-naïve Children with Crohn's Disease.
    El Mouzan M; Wang F; Al Mofarreh M; Menon R; Al Barrag A; Korolev KS; Al Sarkhy A; Al Asmi M; Hamed Y; Saeed A; Dowd SE; Assiri A; Winter H
    J Crohns Colitis; 2017 May; 11(5):586-592. PubMed ID: 27811291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut microbiota composition in patients with Crohn's disease in Saudi Arabia.
    Alahdal H; Almuneef G; Alkhulaifi MM; Aldibasi O; Aljouie A; Alharbi O; Almohawes ZN; Basingab F; Rejili M
    PLoS One; 2024; 19(4):e0299749. PubMed ID: 38656971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn's disease.
    Rajca S; Grondin V; Louis E; Vernier-Massouille G; Grimaud JC; Bouhnik Y; Laharie D; Dupas JL; Pillant H; Picon L; Veyrac M; Flamant M; Savoye G; Jian R; Devos M; Paintaud G; Piver E; Allez M; Mary JY; Sokol H; Colombel JF; Seksik P
    Inflamm Bowel Dis; 2014 Jun; 20(6):978-86. PubMed ID: 24788220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Impact of NOD2 Variants on Fecal Microbiota in Crohn's Disease and Controls Without Gastrointestinal Disease.
    Kennedy NA; Lamb CA; Berry SH; Walker AW; Mansfield J; Parkes M; Simpkins R; Tremelling M; Nutland S; ; Parkhill J; Probert C; Hold GL; Lees CW
    Inflamm Bowel Dis; 2018 Feb; 24(3):583-592. PubMed ID: 29462388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn's Disease Patients.
    Doherty MK; Ding T; Koumpouras C; Telesco SE; Monast C; Das A; Brodmerkel C; Schloss PD
    mBio; 2018 Mar; 9(2):. PubMed ID: 29535202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome: An explorative study.
    Hong G; Li Y; Yang M; Li G; Qian W; Xiong H; Bai T; Song J; Zhang L; Hou X
    Neurogastroenterol Motil; 2020 Nov; 32(11):e13891. PubMed ID: 32449259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multikingdom characterization of gut microbiota in patients with rheumatoid arthritis and rheumatoid arthritis-associated interstitial lung disease.
    Xing Y; Liu Y; Sha S; Zhang Y; Dou Y; Liu C; Xu M; Zhao L; Wang J; Wang Y; Ma X; Yan Q; Kong X
    J Med Virol; 2024 Jul; 96(7):e29781. PubMed ID: 38961767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut mycobiome alterations in obesity in geographically different regions.
    Zhan H; Wan Y; Sun Y; Xu Z; Zhang F; Yang K; Zhu W; Cheung CP; Tang W; Ng EK; Wong SK; Yeoh YK; Kl Chan F; Miao Y; Zuo T; Zeng Z; Ng SC
    Gut Microbes; 2024; 16(1):2367297. PubMed ID: 38899956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucosa-associated microbiota dysbiosis in colitis associated cancer.
    Richard ML; Liguori G; Lamas B; Brandi G; da Costa G; Hoffmann TW; Pierluigi Di Simone M; Calabrese C; Poggioli G; Langella P; Campieri M; Sokol H
    Gut Microbes; 2018 Mar; 9(2):131-142. PubMed ID: 28914591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants and Interactions of Oral Bacterial and Fungal Microbiota in Healthy Chinese Adults.
    Cheung MK; Chan JYK; Wong MCS; Wong PY; Lei P; Cai L; Lan L; Ho WCS; Yeung ACM; Chan PKS; Chen Z
    Microbiol Spectr; 2022 Feb; 10(1):e0241021. PubMed ID: 35107355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of Flagellin-Specific Adaptive Immunity Reveals Links to Dysbiosis in Patients With Inflammatory Bowel Disease.
    Cook L; Lisko DJ; Wong MQ; Garcia RV; Himmel ME; Seidman EG; Bressler B; Levings MK; Steiner TS
    Cell Mol Gastroenterol Hepatol; 2020; 9(3):485-506. PubMed ID: 31790809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The treatment-naive microbiome in new-onset Crohn's disease.
    Gevers D; Kugathasan S; Denson LA; Vázquez-Baeza Y; Van Treuren W; Ren B; Schwager E; Knights D; Song SJ; Yassour M; Morgan XC; Kostic AD; Luo C; González A; McDonald D; Haberman Y; Walters T; Baker S; Rosh J; Stephens M; Heyman M; Markowitz J; Baldassano R; Griffiths A; Sylvester F; Mack D; Kim S; Crandall W; Hyams J; Huttenhower C; Knight R; Xavier RJ
    Cell Host Microbe; 2014 Mar; 15(3):382-392. PubMed ID: 24629344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The fecal mycobiome in patients with Irritable Bowel Syndrome.
    Das A; O'Herlihy E; Shanahan F; O'Toole PW; Jeffery IB
    Sci Rep; 2021 Jan; 11(1):124. PubMed ID: 33420127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.